Standout Papers

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression 2023 2026 202490
  1. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression (2023)
    Andreas Reif, István Bitter et al. New England Journal of Medicine

Citation Impact

3 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
Illusory generalizability of clinical prediction models
2024 StandoutScience
1 intermediate paper

Works of Thomas Messer being referenced

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
2023 Standout
Equipercentile linking of the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale in a catchment area
2012

Author Peers

Author PMh Clinical Psychology Surgery Epidemiology Last Decade Papers Cites
Thomas Messer 504 236 92 168 71 1.0k
Tao Jiang 3 1 1 2 26 325
Sati P. Bandyopadhyay 21 386
Amjad Mahasneh 14 20 28 535
Thomas F. Knöpfel 2 13 1.0k
Gersom Pape 1 4 423

All Works

Loading papers...

Rankless by CCL
2026